Login | Register

Xgeva (Denosumab) Approved For Giant Cell Tumor Of The Bone Treatment, FDA

Xgeva (denosumab) has been approved by the U.S. FDA for the treatment of GCTB (giant cell tumor of the bone) in adults and skeletally mature adolescents. GCTB is a rare tumor which is usually non-cancerous. Giant cell tumor of the bone typically affects adults aged between 20 and 40 years. In the majority of cases, GCTB remains localized (does not spread)...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *